Health Strategies Group - Pharmaceutical and Biotech Articles

	Managed Markets
	Account Management Advantage NEW
	Best Practices
	Cross-Category Access NEW
	Pharmacy Benefit Managers
	Strategic Accounts

	Specialty Biotech
	Managed Care Complete NEW
	Oncology Performance Edge NEW
	Specialty Pharmacy Management
	Specialty Sales Opportunity Assessment

	Sales Representatives & Managers
	PharmaSME
	SFE Library
	Strategic Selling Outlook

	Institutional Markets
	HospitalSFE
	Institutional Provider Systems

	Government as Payer
	Managed Medicare Rx
	Medicaid Rx Payers

	Managed Markets Consulting


Best Practices analyzes health insurer goals and actions for over 20 outpatient drug categories. The service provides brand teams and customer marketing groups the reimbursement and utilization information necessary to develop strategies and message tactics. For more than seven years, we have surveyed and interviewed pharmacy directors at leading plans, developing the deep relationships needed to provide crucial insights for manufacturers’ best practices. View our 2009 Best Practices in Health Plan Marketing research schedule. View our 2010 Best Practices in Health Plan Marketing research schedule. Click the symbol to expand the headings and view descriptions of our research publications. Access to full publications is by subscription. Nonsubscribers may view summaries of research (available for some publications).	Subscribing Companies Receive Customized onsite briefings Inquiry privileges—ask the questions you need to put the information to work Print copies of research reports & access via a customized website for your company Contact Best Practices
Best Practices Publications
2010 Category Management & Review Spring 2010 April 2010 These annual reports describe how health plans manage categories and brands. They include access strategies, projections for new entrants, formulary review criteria, brand messages, and brand share performance. View Research Summary Antiretrovirals 2010 Asthma agents 2010 COPD agents 2010 Hypoglycemics 2010 Insulins 2010 Proton pump inhibitors 2010 Category Management & Review Summer 2010 July 2010 These annual reports describe how health plans manage categories and brands. They include current reimbursement at commercial and Medicare Part D plans, health plan utilization management strategies, predicted health plan actions due to upcoming market events (e.g., launches, patent losses), and relative performance of brands on major formulary review criteria. View Research Summary Antidepressants 2010 July 2010 Antipsychotics 2010 July 2010 Dyslipidemia agents 2010 July 2010 Category Management & Review Fall 2010 Coming September 2010 These annual reports describe how health plans manage categories and brands. They include access strategies, projections for new entrants, formulary review criteria, brand messages, and brand share performance. Antiepileptics 2010 Coming September 2010 Antihypertensives 2010 Coming September 2010 Migraine agents 2010 Coming September 2010 Neuropathic pain agents 2010 Coming September 2010 Oral antiplatelets 2010 Coming September 2010 Osteoporosis agents 2010 Coming September 2010 Category Management & Review Winter 2010 Coming November 2010 These annual reports describe how health plans manage categories and brands. They include current reimbursement at commercial and Medicare Part D plans, health plan utilization management strategies, predicted health plan actions due to upcoming market events (e.g., launches, patent losses), and relative performance of brands on major formulary review criteria. Alzheimer's agents 2010 Coming November 2010 Anticoagulants 2010 Coming November 2010 Hepatitis C agents 2010 Coming November 2010 IBS agents 2010 Coming November 2010 Multiple Sclerosis agents 2010 Coming November 2010 2009 Category Management & Review Spring 2009 April 2009 These annual reports describe how health plans manage categories and brands. They include access strategies, projections for new entrants, formulary review criteria, brand messages, and brand share performance. View Research Summary Antiretrovirals 2009 Asthma Agents 2009 Hypoglycemics 2009 Insulins 2009 Overactive Bladder Agents 2009 Proton Pump Inhibitors 2009 Category Management & Review Summer 2009 July 2009 These annual reports describe how health plans manage categories and brands. They include current reimbursement at commercial and Medicare Part D plans, health plan utilization management strategies, predicted health plan actions due to upcoming market events (e.g., launches, patent losses), and relative performance of brands on major formulary review criteria. View Research Summary Allergy Agents 2009 Antidepressants 2009 Antipsychotics 2009 COPD Agents 2009 Migraine Agents 2009 Oral Antiplatelets 2009 Category Management & Review Fall 2009 September 2009 These annual reports describe how health plans manage categories and brands. They include current reimbursement at commercial and Medicare Part D plans, health plan utilization management strategies, predicted health plan actions due to upcoming market events (e.g., launches, patent losses), and relative performance of brands on major formulary review criteria. View Research Summary Antiepileptics 2009 Antihypertensives 2009 Autoimmune Agents 2009 Dyslipidemia Agents 2009 Osteoporosis Agents 2009 Sleep Disorder Agents 2009 Category Management & Review Winter 2009 December 2009 These annual reports describe how health plans manage categories and brands. They include access strategies, projections for new entrants, formulary review criteria, brand messages, and brand share performance. View Research Summary ADHD 2009 December 2009 Alzheimer's Agents 2009 December 2009 BPH Agents 2009 December 2009 Hepatitis C Agents 2009 December 2009 IBS Agents 2009 December 2009 Multiple Sclerosis Agents 2009 December 2009